Novavax exec says its new COVID shot should work against variants on the rise, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Protein-based vaccines like Novavax’s take longer to produce than the messenger RNA-based (mRNA) versions made by Moderna and Pfizer/BioNTech, this year it had begun producing a version of the vaccine to target the currently dominant XBB.1.5 variant of the virus at commercial scale., Protein-based vaccines like Novavax’s take longer to produce than the messenger RNA-based (mRNA) versions made by Moderna and Pfizer/BioNTech, this year it had begun producing a version of the vaccine to target the currently dominant XBB.1.5 variant of the virus at commercial scale., , Read More